SENORES PHARMACEUTICALS
|
SENORES PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹398 Cr | ₹215 Cr | ₹35 Cr | ₹14 Cr |
| Sales | ₹320 Cr | ₹188 Cr | ₹32 Cr | ₹8.55 Cr |
| Job Work/ Contract Receipts | ₹1.41 Cr | ₹0.22 Cr | - | - |
| Processing Charges / Service Income | ₹59 Cr | ₹19 Cr | ₹3.43 Cr | ₹5.62 Cr |
| Revenue from property development | - | - | - | - |
| Other Operational Income | ₹18 Cr | ₹6.43 Cr | - | - |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹398 Cr | ₹215 Cr | ₹35 Cr | ₹14 Cr |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | ₹-0.76 Cr | ₹3.88 Cr | ₹-0.48 Cr | ₹-2.40 Cr |
| Raw Material Consumed | ₹181 Cr | ₹102 Cr | ₹13 Cr | ₹10 Cr |
| Opening Raw Materials | ₹19 Cr | ₹0.17 Cr | ₹0.43 Cr | ₹0.34 Cr |
| Purchases Raw Materials | ₹107 Cr | ₹51 Cr | ₹0.09 Cr | ₹0.09 Cr |
| Closing Raw Materials | ₹35 Cr | ₹19 Cr | ₹0.17 Cr | ₹0.43 Cr |
| Other Direct Purchases / Brought in cost | ₹90 Cr | ₹70 Cr | ₹13 Cr | ₹10 Cr |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | ₹9.66 Cr | ₹2.93 Cr | - | - |
| Electricity & Power | ₹9.66 Cr | ₹2.93 Cr | - | - |
| Oil, Fuel & Natural gas | - | - | - | - |
| Coals etc | - | - | - | - |
| Other power & fuel | - | - | - | - |
| Employee Cost | ₹60 Cr | ₹35 Cr | ₹4.79 Cr | ₹2.86 Cr |
| Salaries, Wages & Bonus | ₹58 Cr | ₹34 Cr | ₹4.42 Cr | ₹2.70 Cr |
| Contributions to EPF & Pension Funds | ₹1.96 Cr | ₹1.63 Cr | ₹0.31 Cr | ₹0.16 Cr |
| Workmen and Staff Welfare Expenses | ₹0.91 Cr | ₹0.32 Cr | ₹0.07 Cr | ₹0.01 Cr |
| Other Employees Cost | - | - | - | - |
| Other Manufacturing Expenses | ₹37 Cr | ₹14 Cr | ₹0.06 Cr | ₹0.04 Cr |
| Sub-contracted / Out sourced services | - | - | - | - |
| Processing Charges | ₹8.58 Cr | ₹2.69 Cr | - | - |
| Repairs and Maintenance | ₹6.72 Cr | ₹2.72 Cr | ₹0.03 Cr | ₹0.04 Cr |
| Packing Material Consumed | - | - | - | - |
| Other Mfg Exp | ₹21 Cr | ₹8.37 Cr | ₹0.03 Cr | - |
| General and Administration Expenses | ₹18 Cr | ₹14 Cr | ₹4.42 Cr | ₹1.25 Cr |
| Rent , Rates & Taxes | ₹2.73 Cr | ₹0.51 Cr | ₹0.04 Cr | ₹0.01 Cr |
| Insurance | ₹2.11 Cr | ₹3.11 Cr | ₹0.03 Cr | ₹0.03 Cr |
| Printing and stationery | ₹0.46 Cr | ₹0.16 Cr | ₹0.25 Cr | ₹0.02 Cr |
| Professional and legal fees | ₹4.24 Cr | ₹5.35 Cr | ₹3.61 Cr | ₹0.86 Cr |
| Traveling and conveyance | ₹3.36 Cr | ₹1.49 Cr | ₹0.45 Cr | ₹0.30 Cr |
| Other Administration | ₹4.82 Cr | ₹2.96 Cr | ₹0.03 Cr | ₹0.04 Cr |
| Selling and Distribution Expenses | ₹3.23 Cr | ₹0.85 Cr | ₹0.38 Cr | ₹0.03 Cr |
| Advertisement & Sales Promotion | ₹3.23 Cr | ₹0.85 Cr | ₹0.38 Cr | ₹0.03 Cr |
| Sales Commissions & Incentives | - | - | - | - |
| Freight and Forwarding | - | - | - | - |
| Handling and Clearing Charges | - | - | - | - |
| Other Selling Expenses | - | - | - | - |
| Miscellaneous Expenses | ₹0.33 Cr | ₹0.21 Cr | ₹0.24 Cr | - |
| Bad debts /advances written off | - | - | - | - |
| Provision for doubtful debts | - | ₹0.08 Cr | - | - |
| Losson disposal of fixed assets(net) | - | ₹0.03 Cr | - | - |
| Losson foreign exchange fluctuations | - | - | - | - |
| Losson sale of non-trade current investments | - | - | ₹0.00 Cr | - |
| Other Miscellaneous Expenses | ₹0.33 Cr | ₹0.10 Cr | ₹0.24 Cr | - |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹309 Cr | ₹173 Cr | ₹23 Cr | ₹12 Cr |
| Operating Profit (Excl OI) | ₹90 Cr | ₹42 Cr | ₹13 Cr | ₹1.95 Cr |
| Other Income | ₹19 Cr | ₹2.82 Cr | ₹3.68 Cr | ₹0.46 Cr |
| Interest Received | ₹7.16 Cr | ₹0.46 Cr | ₹0.04 Cr | ₹0.19 Cr |
| Dividend Received | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - |
| Profits on sale of Investments | - | - | - | - |
| Provision Written Back | ₹0.07 Cr | - | - | - |
| Foreign Exchange Gains | ₹3.40 Cr | ₹1.07 Cr | ₹3.42 Cr | ₹0.27 Cr |
| Others | ₹8.70 Cr | ₹1.29 Cr | ₹0.22 Cr | - |
| Operating Profit | ₹109 Cr | ₹44 Cr | ₹16 Cr | ₹2.41 Cr |
| Interest | ₹22 Cr | ₹9.45 Cr | ₹2.14 Cr | ₹0.57 Cr |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹19 Cr | ₹8.13 Cr | - | - |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | ₹1.18 Cr | ₹0.95 Cr | ₹0.30 Cr | ₹0.06 Cr |
| Other Interest | ₹1.16 Cr | ₹0.37 Cr | ₹1.84 Cr | ₹0.51 Cr |
| PBDT | ₹87 Cr | ₹35 Cr | ₹14 Cr | ₹1.85 Cr |
| Depreciation | ₹17 Cr | ₹10.00 Cr | ₹1.78 Cr | ₹0.71 Cr |
| Profit Before Taxation & Exceptional Items | ₹71 Cr | ₹25 Cr | ₹12 Cr | ₹1.14 Cr |
| Exceptional Income / Expenses | - | - | - | - |
| Profit Before Tax | ₹71 Cr | ₹25 Cr | ₹12 Cr | ₹1.14 Cr |
| Provision for Tax | ₹12 Cr | ₹-7.77 Cr | ₹4.00 Cr | ₹0.15 Cr |
| Current Income Tax | ₹16 Cr | ₹8.00 Cr | ₹1.43 Cr | ₹0.17 Cr |
| Deferred Tax | ₹-3.33 Cr | ₹-16 Cr | ₹2.58 Cr | ₹-0.02 Cr |
| Other taxes | - | - | - | - |
| Profit After Tax | ₹58 Cr | ₹33 Cr | ₹8.43 Cr | ₹0.99 Cr |
| Extra items | - | - | - | - |
| Minority Interest | ₹0.22 Cr | ₹-1.25 Cr | - | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹59 Cr | ₹31 Cr | ₹8.43 Cr | ₹0.99 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹42 Cr | ₹10 Cr | ₹1.68 Cr | ₹0.69 Cr |
| Appropriations | ₹100 Cr | ₹42 Cr | ₹10 Cr | ₹1.68 Cr |
| General Reserves | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | ₹10 Cr | - | - | - |
| Equity Dividend % | - | - | - | - |
| Earnings Per Share | ₹12.72 | ₹10.31 | ₹8.59 | ₹1.13 |
| Adjusted EPS | ₹12.72 | ₹10.31 | ₹8.59 | ₹1.13 |
Compare Income Statement of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,097.9 Cr | 2.4% | -2.6% | 93.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 2.4% |
-2.6% |
93.2% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses